Coverage
-
June 11, 2018
The judicial panel overseeing multiple suits accusing Merck & Co. Inc. of conspiring with generic-drug makers to delay the entry of rivals to its cholesterol drug Zetia have centralized the cases in Virginia.
1 other articles on this case.
View all »